GlassScriptPhysician profile
Trumane J Ropos
NPI 1548243140
$4,383.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $882 · 2021: $1,029 · 2022: $752 · 2023: $657 · 2024: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,186.17 | 2019-2024 | Skyrizi, Rinvoq, Humira |
| Amgen INC. | $821.06 | 2019-2023 | Enbrel, Amjevita |
| Glaxosmithkline, LLC. | $570.94 | 2019-2023 | Benlysta |
| E.R. Squibb & Sons, L.L.C. | $395.15 | 2019-2022 | |
| Janssen Biotech, INC. | $321.36 | 2020-2023 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $247.78 | 2021-2023 | Saphnelo |
| Genentech USA, INC. | $162.02 | 2019 | |
| Ucb, INC. | $137.47 | 2020-2023 | Cimzia |
| Mallinckrodt Hospital Products INC. | $110.33 | 2022-2024 | Acthar |
| Pfizer INC. | $104.84 | 2020-2023 | |
| Lilly USA, LLC | $87.50 | 2022 | |
| Radius Health, INC. | $79.91 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $39.33 | 2021 | |
| Sobi, INC | $35.90 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $28.88 | 2024 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.17 | 2019 | |
| Fresenius Kabi USA, LLC | $17.72 | 2023 | |
| Organon LLC | $16.99 | 2023 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trumane Ropos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.